Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

In response to the Ebola virus (EBOV) crisis of 2013–2016, a recombinant vesicular stomatitis virus (VSV)–based EBOV vaccine was clinically tested (NCT02283099). A single-dose regimen of VSV-EBOV revealed a safe and immunogenic profile and demonstrated clinical efficacy. While EBOV-specific immune r...

Descripción completa

Detalles Bibliográficos
Autores principales: Poetsch, Joseph H, Dahlke, Christine, Zinser, Madeleine E, Kasonta, Rahel, Lunemann, Sebastian, Rechtien, Anne, Ly, My L, Stubbe, Hans C, Krähling, Verena, Biedenkopf, Nadine, Eickmann, Markus, Fehling, Sarah K, Olearo, Flaminia, Strecker, Thomas, Sharma, Piyush, Lang, Karl S, Lohse, Ansgar W, Schmiedel, Stefan, Becker, Stephan, Addo, Marylyn M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350948/
https://www.ncbi.nlm.nih.gov/pubmed/30452666
http://dx.doi.org/10.1093/infdis/jiy565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350948/
https://www.ncbi.nlm.nih.gov/pubmed/30452666
http://dx.doi.org/10.1093/infdis/jiy565

Ejemplares similares